Here are the Rest of the Top 10:
Abbott Laboratories, Ticker: $ABT
Abbott Laboratories, $ABT, had a strong run higher from mid April so you may think it is due for a pullback. And it might do so. But the recent consolidation in a bull flag suggests another leg higher may be in the picture……
Comerica, Ticker: $CMA
Comerica, $CMA, made a high in March before pulling back to near the 200 day SMA in May. the bounce higher consolidated for a month before falling back to the cross of the 50 and 100 day SMA’s last week and then bouncing higher again. The RSI is turning back up and the MACD did as well and is near a positive cross……
CVS Caremark, Ticker: $CVS
CVS Caremark, $CVS, has had a strong trend higher since October 2013 with a pullback at the beginning of the year to refresh things. The price action since May has been mainly sideways with a small Cup and Handle……
Novo Nordisk, Ticker: $NVO
Novo Nordisk, $NVO, had a strong run higher from November until the top in February. A series of lower lows following that led to a jump higher in June and now consolidation. The RSI is bullish and the MACD flat and about to cross positive…..
PNC Financial, Ticker: $PNC
PNC Financial, $PNC, has been trending higher since last October. It has had several pullbacks to the 100 day SMA, including the breach following earnings 2 weeks ago. Now it is back at the 100 day SMA with a rising RSI and a MACD that has stopped falling and is starting to turn higher…..
If you like what you see sign up for the rest of the ideas and deeper analysis here .
After reviewing over 1,000 charts, I have found some good setups for the week. These were selected and should be viewed in the context of the broad Market Macro picture reviewed Friday which, heading into the last days of July, sees the Equity Indexes again are mixed. Elsewhere look for Gold to continue lower in its consolidation while Crude Oil slowly climbs in its broad consolidation. The US Dollar Index is breaking higher and looks to continue in the short run while US Treasuries continue to look good to the upside. The Shanghai Composite and Emerging Markets are also biased to the upside now with the risk that Emerging Markets find resistance. Volatility looks to remain at low levels keeping the bias higher for the equity index ETF’s SPY, IWM and QQQ. There chart paint a mixed picture though with the QQQ looking strong and ready to continue higher while the SPY consolidated in the uptrend and the IWM pulls back in the consolidation range. Use this information as you prepare for the coming week and trad’em well.
Recommended for You
For all his claims that he would be a “law and order” president, it is becoming increasingly clear that Donald Trump and the organizations he runs -- from his multiple businesses to his family foundation -- appear to have a very difficult time obeying the law themselves. A revelation today from The…The Fiscal Times
Berkshire Hathaway (ticker: BRK.A, BRK.B) kingpin Warren Buffett was keeping mum on the Wells Fargo & Co ( WFC) -- until now, given recent speculation on his opinion of the company. Going to the board implies I've gone around [Wells Fargo CEO John] Stumpf, the guy who is under fire," Buffett said…U.S.News & World Report
The strategist who predicted the capital concerns now enveloping Deutsche Bank has some gloomy predictions on what’ll happen next.CNBC
Sept. 30 -- Former Lieutenant Governor of New York Betsy McCaughey, a Donald Trump supporter, discusses the Republican nominees’ Miss Universe controversy on “With All Due Respect.”Bloomberg Video
People in their early 30s are "half as wealthy" as those now in their 40s were at the same age, a report by the Institute for Fiscal Studies finds.BBC News
Donald Trump’s tactically dubious decision to continue his attacks on a former Miss Universe over her weight gain following a disastrous performance in the first presidential debate have caused the question of his treatment of women to flare up yet again. The latest flare-up apparently prompted the…The Fiscal Times
Falling pending-home-sales numbers from August coinciding with falling U.S. mortgage rates suggest that demand may be drying up and that a housing market that has been humming along may be headed for some ...MarketWatch
Jim Cramer lays out three scenarios of how the Deutsche Bank drama could play out.CNBC
Some people are concerned that a highly accurate test that can identify babies with Down's syndrome during pregnancy will lead to more terminations.BBC News
Whether It’s Trump or Clinton, the Next President Will Be One of the Most Secretive in Modern History
Both Donald Trump and Hillary Clinton either don’t understand or simply reject the virtue of transparency. The key reason transparency is so important is the unique power that governments wield. Taxpayers can’t be sure that their tax money has been spent as intended unless government expenditures…The Fiscal Times
When storing your lawnmower for the winter, Consumer Reports' experts say these two tips are must-dos to ensure your mower will be up and running when you need it in the spring.ConsumerReports
Boeing Co. is nearing an agreement with Qatar’s flagship airline for a multibillion-dollar commercial jet order, following U.S. approval of a long-stalled sale of F-15 fighter jets to the Persian Gulf ...Bloomberg
If history repeats, stocks could be in for a sweet end to the year.CNBC.com
MUMBAI (Reuters) - India's end-June external debt was at $479.7 billion, down $5.4 billion from end-March, largely driven by lower offshore borrowings by companies, the Reserve Bank of India (RBI) said ...Reuters
Donald Trump and Hillary Clinton didn’t agree on much during their acerbic debate faceoff earlier this week, but one of the topics on which they found common ground was nuclear weapons. Then he went on to criticize America’s nuclear capabilities compared to those of Russia. What Trump saw “the…The Fiscal Times
If ConocoPhillips can build on the recent upside momentum, the foundation is now in place for a powerful rally phase.TheStreet.com
Sources told Reuters this month that Depomed was preparing to explore a sale and talks with potential buyers are expected to start shortly after a ruling on Nucynta, the company's biggest drug. Activist investor Starboard Value LP in April called on Depomed to explore a sale after disclosing a…Reuters